|
Vaccine Detail
HIV DNA vaccine pCMN160 |
Vaccine Information |
- Vaccine Name: HIV DNA vaccine pCMN160
- Target Pathogen: Human Immunodeficiency Virus
- Target Disease: Acquired Immunodeficiency Syndrome (AIDS)
- Vaccine Ontology ID: VO_0004345
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Chimpanzee
- Antigen: env and rev of HIV-1 strain MN and gag/pol from HIV-1 III8 (Boyer et al., 1997)
- env
gene engineering:
- Type: DNA vaccine construction
- Description: This DNA vaccine encoded env (Boyer et al., 1997).
- Detailed Gene Information: Click Here.
- rev MN isolate
gene engineering:
- Type: DNA vaccine construction
- Description: This DNA vaccine encoded rev (Boyer et al., 1997).
- Detailed Gene Information: Click Here.
- gag-pol
gene engineering:
- Type: DNA vaccine construction
- Description: This DNA vaccine encoded gag/pol from HIV-1 III8 (Boyer et al., 1997).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0005043
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Chimpanzee Response
- Vaccine Immune Response Type: VO_0000286
- Efficacy: Animals were challenged with a heterologous chimpanzee titered stock of HIV-1 SF2 virus. Polymerase chain reaction coupled with reverse transcription results indicated infection in the control animal, whereas those animals vaccinated with the DNA constructs were protected from the establishment of infection (Boyer et al., 1997).
|
References |
Boyer et al., 1997: Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature medicine. 1997; 3(5); 526-532. [PubMed: 9142121].
|
|